Oncolytic HSV and PI3K inhibitor BKM120 synergize to promote killing of prostate cancer stem-like cells.

被引：0
|
作者：
Wang, Lei [1 ]
机构：
[1] Wuhan Univ, Zhongnan Hosp, Wuhan, Hubei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e16503
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16503
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells
    Wang, Lei
    Ning, Jianfang
    Wakimoto, Hiroaki
    Wu, Shulin
    Wu, Chin-lee
    Humphrey, Melissa R.
    Rabkin, Samuel D.
    Martuza, Robert L.
    MOLECULAR THERAPY-ONCOLYTICS, 2019, 13 : 58 - 66
  • [2] Effective use of PI3K inhibitor BKM120 to treat human osteosarcoma
    Lu, Yao
    Wang, Qian
    Fan, Shan
    Hu, Bin
    Sun, Liang
    Xue, Hanzhong
    Zhou, Chengpei
    Zhou, Yong
    Zhang, Kun
    Li, Zhong
    Ma, Teng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (04): : 6378 - 6386
  • [3] Utilizing insulin the treatment of prostate cancer with BKM120 abrogates the therapeutic effect of PI3K pathway inhibition
    Wang, Lily C.
    Kim, Sunnie S.
    Nanus, David M.
    Cantley, Lewis C.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
  • [4] The PI3K inhibitor BKM120 inhibits growth of pancreatic ductal adenocarcinoma in vitro and in vivo
    Tignanelli, Christopher James
    Herrera, Silvia Gabriela
    Torphy, Robert
    Yeh, Jen Jen
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (03) : S137 - S138
  • [5] Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy
    Peng, Xin
    Zhang, Shaolu
    Jiao, Wenhui
    Zhong, Zhenxing
    Yang, Yuqi
    Claret, Francois X.
    Elkabets, Moshe
    Wang, Feng
    Wang, Ran
    Zhong, Yuxu
    Chen, Zhe-Sheng
    Kong, Dexin
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [6] PRE-CLINICAL ACTIVITY OF THE PI3K INHIBITOR BKM120 ON ACUTE MYELOID LEUKEMIA
    Allegretti, M.
    Ricciardi, M. R.
    Licchetta, R.
    Mirabilii, S.
    Amadori, S.
    Foa, R.
    Tafuri, A.
    HAEMATOLOGICA, 2014, 99 : 291 - 291
  • [7] UTILIZING INSULIN IN THE TREATMENT OF PROSTATE CANCER WITH BKM120 ABROGATES THE THERAPEUTIC EFFECT OF PI3K PATHWAY INHIBITION
    Wang, Lily
    Nanus, David
    Cantley, Lewis
    JOURNAL OF UROLOGY, 2015, 193 (04): : E547 - E547
  • [8] Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cell in human breast cancer cells.
    Zhang, Jin
    Hu, Yunhui
    Zhou, Yang
    Liu, Jingjing
    Zhang, Sheng
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] The effect of the PI3K inhibitor BKM120 on tumour growth and osteolytic bone disease in multiple myeloma
    Martin, Sally
    Gan, Zhen Ying
    Fitter, Stephen
    To, Luen B.
    Zannettino, Andrew C. W.
    LEUKEMIA RESEARCH, 2015, 39 (03) : 380 - 387
  • [10] Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy
    Xin Peng
    Shaolu Zhang
    Wenhui Jiao
    Zhenxing Zhong
    Yuqi Yang
    Francois X. Claret
    Moshe Elkabets
    Feng Wang
    Ran Wang
    Yuxu Zhong
    Zhe-Sheng Chen
    Dexin Kong
    Journal of Experimental & Clinical Cancer Research, 40
12345